Evaluation of American (Sambucus canadensis) and European (S. nigra) elderberry genotypes grown in diverse environments and implications for cultivar development

American (Sambucus canadensis L.) elderberry genotypes were evaluated at multiple locations, whereas European (S. nigra L.) elderberry genotypes were evaluated at a single location to assess genotypic differences and, for genotypes evaluated at multiple locations, to determine genotype x environment interactions (G x E). Seventeen S. canadensis genotypes were planted in replicated trials at Missouri State University (Mountain Grove, MO) and at the University of Missouri (Mt. Vernon, MO) or at the U.S. Department of Agriculture-Agricultural Research Service in Oregon (Corvallis). \u27Johns\u27, \u27Netzer\u27, \u27Adams II\u27, and \u27Gordon B\u27 were in common at all locations. In addition, three genotypes of S. nigra, which are not winter-hardy in Missouri, were planted in Oregon. All plants were established in 2003 and evaluated in 2004, 2005, and, for some traits, in 2006. Plants were evaluated for phenology (e.g., dates of budbreak, first flowering, full flowering, and first ripening), vegetative growth (e.g., number of shoots and plant height), yield components (e.g., total yield, number of cymes, cyme weight, and berry weight), and for pest incidence (e.g., eriophyid mites). For the genotypes in common to all locations, there were significant differences resulting from genotype, location, year, and the interactions for various traits. Although the trend was for Corvallis to have the highest and Mt. Vernon the lowest yield, there was no significant location effect. The significant genotype x environment interaction appeared to be primarily the result of the differential performance of \u27Johns\u27, which was generally high-yielding in Corvallis and low-yielding at both Missouri locations. The significant G x E suggests that as the Missouri institutions develop new cultivars, it will be important to test them individually at other locations and not rely on their relative performance compared with standards in Missouri. For the genotypes in common to the two Missouri sites, there was significant variation for many traits. Although there were no differences among genotypes for yield across the locations, there was a significant G x E. Although there were some small changes in performance among the sites for yield, the most dramatic changes were for \u27Wyldewood 1\u27 that was the second highest yielding genotype at Mountain Grove and the second worst at Mt. Vernon. Plant growth in Oregon was 40% and 60% greater than at Mountain Grove and Mt. Vernon, respectively, when the plants were first measured. In Oregon, the two Sambucus species behaved differently. Phenologically, although the S. nigra genotypes flowered ≈3 weeks earlier than the S. canadensis genotypes, they ripened at the same time, thereby shortening their exposure to potential biotic and abiotic stress. \u27Johns\u27, \u27York\u27, \u27Golden\u27, and \u27Gordon B\u27 were the highest yielding S. canadensis genotypes and \u27Korsør\u27 the highest of the S. nigra genotypes. Although \u27Korser\u27 is considered high-yielding in Denmark, it did not yield as well as the highest yielding S. canadensis cultivars

Growing and Marketing Elderberries in Missouri (2012)

The American elderberry (Sambucus canadensis, also known as Sambucus nigra subsp. canadensis) is native to much of eastern and midwestern North America. The plant is a medium to large multiple-stemmed shrub, bush or small tree. Elderberry is commonly found growing in a range of habitats throughout Missouri, but it prefers moist, well-drained, sunny sites and is often found along roadside ditches and streams.By Patrick L. Byers, Andrew L. Thomas, Mihaela M. Cernusca, Larry D. Godsey and Michael A. Gold (University of Missouri)Includes bibliographical reference

A comparison of fruit characteristics among diverse elderberry genotypes grown in Missouri and Oregon

Abstract. BACKGROUND: Elderberry (Sambucus spp.) fruit are used for food and dietary supplements in Europe and North America, and contain large amounts of cyanidin-based anthocyanins and other phenolics that may benefit human health. OBJECTIVES: Information on the effect of both genotype and production environment on elderberry juice characteristics is needed in order to optimize production of quality food and dietary supplements. METHODS: The characteristics of elderberry fruits relative to genetic and production environment were evaluated from 12 American elderberry genotypes at three U.S. sites (two in Missouri and one in Oregon) over three growing seasons. Additional genotypes of American and European elderberry were studied at the Oregon site. RESULTS: Location, genotype, and growing season influenced pH, soluble solids, titratable acidity, total phenolics, and total anthocyanins. Elderberries grown in Oregon were consistently higher in acidity than those grown in Missouri. Differences in acidity and anthocyanin with environment were dependent on genotype. Non-acylated anthocyanins and flavonol-glycosides were more influenced by location than by genotype. CONCLUSION: 'Bob Gordon' and 'Adams 2' genotypes, which are good producers in diverse environments, were significantly higher in total phenolic and total anthocyanin contents in all locations, and may be good selections for producing juices, wines, or health products

Rickettsia parkeri Infection after Tick Bite, Virginia

We describe a man with a febrile illness and an eschar that developed at the site of a tick bite. Rickettsia parkeri was detected and isolated from the eschar. This report represents the second documented case of R. parkeri rickettsiosis in a US serviceman in eastern Virginia

The macroecology of infectious diseases: a new perspective on global-scale drivers of pathogen distributions and impacts

© 2016 John Wiley & Sons Ltd/CNRS. Identifying drivers of infectious disease patterns and impacts at the broadest scales of organisation is one of the most crucial challenges for modern science, yet answers to many fundamental questions remain elusive. These include what factors commonly facilitate transmission of pathogens to novel host species, what drives variation in immune investment among host species, and more generally what drives global patterns of parasite diversity and distribution? Here we consider how the perspectives and tools of macroecology, a field that investigates patterns and processes at broad spatial, temporal and taxonomic scales, are expanding scientific understanding of global infectious disease ecology. In particular, emerging approaches are providing new insights about scaling properties across all living taxa, and new strategies for mapping pathogen biodiversity and infection risk. Ultimately, macroecology is establishing a framework to more accurately predict global patterns of infectious disease distribution and emergence

Colorectal cancer screening among African American church members: A qualitative and quantitative study of patient-provider communication

BACKGROUND: A healthcare provider's recommendation to undergo screening has been shown to be one of the strongest predictors of completing a colorectal cancer (CRC) screening test. We sought to determine the relationship between the general quality of self-rated patient-provider communication and the completion of CRC screening. METHODS: A formative study using qualitative data from focus groups and quantitative data from a cross-sectional survey of church members about the quality of their communication with their healthcare provider, their CRC risk knowledge, and whether they had completed CRC screening tests. Focus group participants were a convenience sample of African American church members. Participants for the survey were recruited by telephone from membership lists of 12 African American churches located in rural counties of North Carolina to participate in the WATCH (Wellness for African Americans Through Churches) Project. RESULTS: Focus Groups. Six focus groups (n = 45) were conducted prior to the baseline survey. Discussions focused on CRC knowledge, and perceived barriers/motivators to CRC screening. A theme that emerged during each groups' discussion about CRC screening was the quality of the participants' communication with their health care provider. Survey. Among the 397 participants over age 50, 31% reported CRC screening within the recommended guidelines. Participants who self-rated their communication as good were more likely to have been screened (36%) within the recommended guidelines than were participants with poor communication (17%) (OR = 2.8, 95% CI 1.2, 6.4; p = 0.013). Participants who had adequate CRC knowledge completed CRC screening at a higher rate than those with inadequate knowledge (p = 0.011). The percentage of participants with CRC screening in the recommended guidelines, stratified by communication and knowledge group were: 42% for good communication/adequate knowledge; 27% for good communication/inadequate knowledge; 29% for poor communication/adequate knowledge; and 5% for poor communication/inadequate knowledge. CONCLUSIONS: Participants who rated their patient-provider communication as good were more likely to have completed CRC screening tests than those reporting poor communication. Among participants reporting good communication, knowledge about colorectal cancer was also associated with test completion. Interventions to improve patient-provider communication may be important to increase low rates of CRC screening test completion among African Americans

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

This integrated, multiplatform PanCancer Atlas study co-mapped and identified distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites associated with smokin

Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement

Periodontal Ehlers-Danlos syndrome (pEDS) is an autosomal-dominant disorder characterized by early-onset periodontitis leading to premature loss of teeth, joint hypermobility, and mild skin findings. A locus was mapped to an approximately 5.8 Mb region at 12p13.1 but no candidate gene was identified. In an international consortium we recruited 19 independent families comprising 107 individuals with pEDS to identify the locus, characterize the clinical details in those with defined genetic causes, and try to understand the physiological basis of the condition. In 17 of these families, we identified heterozygous missense or in-frame insertion/deletion mutations in C1R (15 families) or C1S (2 families), contiguous genes in the mapped locus that encode subunits C1r and C1s of the first component of the classical complement pathway. These two proteins form a heterotetramer that then combines with six C1q subunits. Pathogenic variants involve the subunit interfaces or inter-domain hinges of C1r and C1s and are associated with intracellular retention and mild endoplasmic reticulum enlargement. Clinical features of affected individuals in these families include rapidly progressing periodontitis with onset in the teens or childhood, a previously unrecognized lack of attached gingiva, pretibial hyperpigmentation, skin and vascular fragility, easy bruising, and variable musculoskeletal symptoms. Our findings open a connection between the inflammatory classical complement pathway and connective tissue homeostasis

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

Despite rapid technical progress and demonstrable effectiveness for some types of diagnosis and therapy, much remains to be learned about clinical genome and exome sequencing (CGES) and its role within the practice of medicine. The Clinical Sequencing Exploratory Research (CSER) consortium includes 18 extramural research projects, one National Human Genome Research Institute (NHGRI) intramural project, and a coordinating center funded by the NHGRI and National Cancer Institute. The consortium is exploring analytic and clinical validity and utility, as well as the ethical, legal, and social implications of sequencing via multidisciplinary approaches; it has thus far recruited 5,577 participants across a spectrum of symptomatic and healthy children and adults by utilizing both germline and cancer sequencing. The CSER consortium is analyzing data and creating publically available procedures and tools related to participant preferences and consent, variant classification, disclosure and management of primary and secondary findings, health outcomes, and integration with electronic health records. Future research directions will refine measures of clinical utility of CGES in both germline and somatic testing, evaluate the use of CGES for screening in healthy individuals, explore the penetrance of pathogenic variants through extensive phenotyping, reduce discordances in public databases of genes and variants, examine social and ethnic disparities in the provision of genomics services, explore regulatory issues, and estimate the value and downstream costs of sequencing. The CSER consortium has established a shared community of research sites by using diverse approaches to pursue the evidence-based development of best practices in genomic medicine

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype1-3. To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 × 10-8), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate < 0.05). Five loci showed associations (P < 0.05) in opposite directions between luminal and non-luminal subtypes. In silico analyses showed that these five loci contained cell-specific enhancers that differed between normal luminal and basal mammary cells. The genetic correlations between five intrinsic-like subtypes ranged from 0.35 to 0.80. The proportion of genome-wide chip heritability explained by all known susceptibility loci was 54.2% for luminal A-like disease and 37.6% for triple-negative disease. The odds ratios of polygenic risk scores, which included 330 variants, for the highest 1% of quantiles compared with middle quantiles were 5.63 and 3.02 for luminal A-like and triple-negative disease, respectively. These findings provide an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores